The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy

Clinical trial NCT06599697 · RECRUITING

Trial details

NCT number: NCT06599697
Sponsor: University of Alabama at Birmingham
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anti-3-hydroxy-3-methylglutaryl-CoA Reductase (HMGCR) Immune-Mediated Necrotizing Myopathy

Start date: 2025-10-27
Primary completion: 2026-12-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.